Bagheri-Yarmand R - Search Results

1

The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses c-Src and Pak1 pathways and invasiveness of human cancer cells.

Yang Z, Bagheri-Yarmand R, Wang RA, Adam L, Papadimitrakopoulou VV, Clayman GL, El-Naggar A, Lotan R, Barnes CJ, Hong WK, Kumar R. Yang Z, et al. Clin Cancer Res. 2004 Jan 15;10(2):658-67. doi: 10.1158/1078-0432.ccr-0382-03. Clin Cancer Res. 2004. PMID: 14760089

2

Antihuman epidermal growth factor receptor 2 antibody herceptin inhibits autocrine motility factor (AMF) expression and potentiates antitumor effects of AMF inhibitors.

Talukder AH, Bagheri-Yarmand R, Williams RR, Ragoussis J, Kumar R, Raz A. Talukder AH, et al. Clin Cancer Res. 2002 Oct;8(10):3285-9. Clin Cancer Res. 2002. PMID: 12374700

3

Suppression of epidermal growth factor receptor, mitogen-activated protein kinase, and Pak1 pathways and invasiveness of human cutaneous squamous cancer cells by the tyrosine kinase inhibitor ZD1839 (Iressa).

Barnes CJ, Bagheri-Yarmand R, Mandal M, Yang Z, Clayman GL, Hong WK, Kumar R. Barnes CJ, et al. Mol Cancer Ther. 2003 Apr;2(4):345-51. Mol Cancer Ther. 2003. PMID: 12700278

4

HER2 regulation of peroxisome proliferator-activated receptor gamma (PPARgamma) expression and sensitivity of breast cancer cells to PPARgamma ligand therapy.

Yang Z, Bagheri-Yarmand R, Balasenthil S, Hortobagyi G, Sahin AA, Barnes CJ, Kumar R. Yang Z, et al. Clin Cancer Res. 2003 Aug 1;9(8):3198-203. Clin Cancer Res. 2003. PMID: 12912973

5

p41-Arc subunit of human Arp2/3 complex is a p21-activated kinase-1-interacting substrate.

Vadlamudi RK, Li F, Barnes CJ, Bagheri-Yarmand R, Kumar R. Vadlamudi RK, et al. EMBO Rep. 2004 Feb;5(2):154-60. doi: 10.1038/sj.embor.7400079. Epub 2004 Jan 23. EMBO Rep. 2004. PMID: 14749719 Free PMC article.

6

A naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm.

Kumar R, Wang RA, Mazumdar A, Talukder AH, Mandal M, Yang Z, Bagheri-Yarmand R, Sahin A, Hortobagyi G, Adam L, Barnes CJ, Vadlamudi RK. Kumar R, et al. Nature. 2002 Aug 8;418(6898):654-7. doi: 10.1038/nature00889. Nature. 2002. PMID: 12167865

7

Essential functions of p21-activated kinase 1 in morphogenesis and differentiation of mammary glands.

Wang RA, Vadlamudi RK, Bagheri-Yarmand R, Beuvink I, Hynes NE, Kumar R. Wang RA, et al. J Cell Biol. 2003 May 12;161(3):583-92. doi: 10.1083/jcb.200212066. Epub 2003 May 5. J Cell Biol. 2003. PMID: 12732616 Free PMC article.

8

Emerging roles of MTA family members in human cancers.

Kumar R, Wang RA, Bagheri-Yarmand R. Kumar R, et al. Semin Oncol. 2003 Oct;30(5 Suppl 16):30-7. doi: 10.1053/j.seminoncol.2003.08.005. Semin Oncol. 2003. PMID: 14613024 Review.

9

Dynein light chain 1, a p21-activated kinase 1-interacting substrate, promotes cancerous phenotypes.

Vadlamudi RK, Bagheri-Yarmand R, Yang Z, Balasenthil S, Nguyen D, Sahin AA, den Hollander P, Kumar R. Vadlamudi RK, et al. Cancer Cell. 2004 Jun;5(6):575-85. doi: 10.1016/j.ccr.2004.05.022. Cancer Cell. 2004. PMID: 15193260 Free article.

10

LIM kinase 1 increases tumor metastasis of human breast cancer cells via regulation of the urokinase-type plasminogen activator system.

Bagheri-Yarmand R, Mazumdar A, Sahin AA, Kumar R. Bagheri-Yarmand R, et al. Int J Cancer. 2006 Jun 1;118(11):2703-10. doi: 10.1002/ijc.21650. Int J Cancer. 2006. PMID: 16381000

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters